Gelonghui November 30: Some investors asked Kanghui Pharmaceutical (603139.SH) on the investor interactive platform, “Has the company submitted an application for the GMP inspection company to build a new pharmaceutical production base?”

The company said that all of the company's new pharmaceutical production bases have been built, and preparations for GMP compliance checks are currently being carried out. If relevant progress is made in the future, the company will promptly issue relevant announcements.